Investor Pitch — 2026
Therapoice is an AI voice-guided home therapy system for neurodivergent children. Built by 9T5. Validated by Kind Corner. Funded by the NDIS market.
The home practice gap is the biggest unsolved problem in paediatric therapy. And nobody has built an Australian product to close it.
"Daily home practice is the single biggest driver of therapy outcomes for neurodivergent children. The research on this is not disputed. The problem is structural — families don't have the tools to do it consistently."
Clinical consensus — ASHA 2024, PMC systematic reviews 2025Therapoice puts a structured, therapist-designed program on every child's device. No clinical training needed. Just open the app.
Logs into the therapist panel. Chooses exercises, sets the order, records voice prompts. Assigns the program to the child.
Opens the app. A friendly, consistent voice walks them through each activity. No reading required. No clinical training needed from the parent.
Parent dashboard shows what was completed and how engagement is trending. Therapist gets the data before the next session. No catching up needed.
Therapoice is designed to improve outcomes for participants, providers, product partners, and government at the same time.
More frequent home practice, clearer routines, less weekly stress, and better progress toward NDIS-aligned goals between sessions.
Lower home-program admin load, cleaner engagement data before each consult, and higher-value sessions focused on next actions.
Faster product validation, stronger local IP, and a practical commercial path to scale from speech therapy into adjacent disciplines.
Better continuity of support, clearer home-practice documentation, and a measurable model aligned with early intervention priorities.
Neither is starting from scratch. The technology exists. The clinical relationships exist. This is commercialisation, not exploration.
9T5 has been building production-ready technology systems since 2017. Operating across 4+ countries, they work with companies in healthcare, disability services, telecom, employment, finance, cybersecurity, retail, logistics, education, and public sector programs to design and deliver platforms, data systems, AI agents, and security programs. The core technology stack for Therapoice already exists inside 9T5's capability base. They are not learning voice AI for healthcare - they are applying what they already know to the fastest-growing underserved segment of the Australian health market.
Kind Corner was registered in April 2024. Its founders had worked with neurodivergent children in South East Melbourne for years before that in a personal capacity. They design the exercises, validate the clinical content, and run the pilot. They are also the first customer — which means the feedback loop from build to clinical use starts on day one.
The NDIS is one of the largest disability funding systems in the world. The demand for home-based paediatric support is growing every year.
10 Kind Corner therapists, 10 families each. 100 active families in the first 12 months. Clinic-paid software model with clear monthly reporting. Real engagement data. Real outcomes. Proof the model works before we expand.
NDIS providers must document home programs for goal-tracking. Therapoice becomes the infrastructure for that documentation. 1% of 170,000 children is 1,700 active families before we expand to OT, physio, and emotional regulation.
Therapoice is sold to NDIS-registered clinics as software that drives home practice between sessions. It is not sold as a therapist replacement. Pricing is benchmarked against Australian allied health software, with higher value because this is family-facing and outcome-linked.
$39 AUD per active family/month on annual commitment, or $49 month-to-month. Therapist configures the program, parent and child use the app at no extra cost.
$99 AUD per therapist seat/month on annual commitment, or $129 month-to-month. Fixed clinic spend with unlimited families per seat.
Free for first 5 active families, then $39 annual / $49 month-to-month per family. Optional parent premium: $19 annual / $24 month-to-month.
Pricing anchor: Splose ($25/practitioner/month), Cliniko ($49 to $349/month tiered), Halaxy (free core plus usage fees). Therapoice sits above pure admin tools because it creates between-session engagement and evidence, not just scheduling.
Therapoice qualifies for the federal Industry Growth Program under two separate priority areas. We are asking for a conservative $50,000 Phase 1 funding tranche with monthly delivery reporting.
This funds a launchable MVP in a disciplined scope. It is a non-equity ask and fits the Industry Growth Program pathway for Australian commercialisation in priority sectors.
Directly therapeutic technology for a diagnosed population. Designed with a registered clinical partner. Clear health outcome.
AI voice interaction system as the core enabling technology. Built and owned by an Australian company. Not a US product resold locally.
Each month we publish sprint milestones delivered, active pilot families, therapist adoption, usage trends, and a traffic-light risk register with mitigation actions.
A decade-long government commitment to improved access to therapy and support for autistic Australians.
Federal and State governments jointly committed to early childhood support for children aged 8 and under with developmental delay and autism.
The MRFF has invested over $30 million in AI health research including programs targeting disability support and better outcomes.
This ask is specific: secure $50,000 for a launchable Phase 1 build and deliver against monthly transparent reporting.
Fund a tightly scoped launchable MVP: speech module, therapist panel, parent dashboard, and engagement analytics needed for pilot execution.
9T5 engineering hours, co-founder product leadership, and Kind Corner clinical design to ship a launchable MVP and run the 100-family pilot.
Share monthly product milestones, pilot cohort progress, engagement and satisfaction metrics, and a documented risk register with mitigations.
The landing page is built. The research brief is done. The clinical partner is confirmed. The next steps are build and pilot execution.
Finalise speech-first MVP scope: child voice flow, therapist panel, parent dashboard, and admin baseline analytics.
Engineering build begins with weekly milestones and risk tracking across product, clinical, and operations workstreams.
Kind Corner validates exercise library, prompt quality, progression logic, and therapist workflows for pilot families.
10 therapists x 10 families, 12 months of engagement and outcomes data, with monthly reporting and iterative product improvements.
Disability technology is one of the most actively acquired categories in Australian health. We are building a durable, data-rich asset in a growing sector.
Direct contact: salam@9t5.com.au · liaqat@9t5.com.au